Previous webinar
Oct 17, 2024
1 PM (CET)
MS-Teams
recorded
THREE
Webinar THREE was dedicated to pediatric case reports and Eleva’s CPV-104 study program.
Speakers
Antonia King
Member and speaker of the German self-help group for complement mediated diseases aHUS and MPGN.
Challenges with a rare kidney disease
Prof. Sevcan Bakkaloğlu
Gazi University, Ankara
C3 Glomerulopathy in Children
Dr. Andreas Schaaf
CSO and Managing Director, eleva GmbH
Recombinant Factor H (CPV-104) – produced in moss
Our webinar series offers firsthand insights from experts, scientists, and clinicians about C3 Glomerulopathy (C3G) and Fabry Disease such as epidemiology, diagnosis, treatment, management, and coping strategies. You will hear about all the relevant aspects, including Eleva’s initiatives to develop new treatment options for these rare diseases with high unmet medical needs. Join the series for regular updates on Eleva’s clinical development efforts.
Stay in the loop
Next webinars
Back to